CompletedNCT02651584
CAM2038 Buprenorphine Injections for Opioid Dependence
About this title
Read the official source — NCT02651584Medication studyAges 18–65United StatesAddiction
Understand this study
Who was this study for?
Listed age limits: 18 years to 65 years.
- Listed locations
- Birmingham and 35 more locationsSee all locations and recruitment
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
Study information
Study start dateDecember 2015
- Recruitment status
- Completed
- Enrollment listed in the registry
- 428
- Sponsor
- Braeburn Pharmaceuticals
- Sponsor type
- Unknown or unclear
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 3Usually a larger study designed to confirm effectiveness and safety in a broader group.
- Locations
- United States
- Age range
- From 18 Years to 65 Years
- Official registry ID
- NCT02651584
- Official title
Show the full official title
A Phase III, Randomized, Double-Blind, Active-Controlled, Parallel Group, Multi-center Trial Assessing the Efficacy and Safety of a Once-Weekly and Once-Monthly, Long-Acting Subcutaneous Injectable Depot of Buprenorphine (CAM2038) in Treatment of Adult Outpatients With Opioid Use Disorder
Looking for a study you can join?
Explore recruiting studiesRecruitment & locations
CompletedThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Birmingham · Haleyville · Hamilton
32 more locations
- Lemon Grove
- Oceanside
- Panorama City
- San Diego
- San Francisco
- West Hollywood
- Jacksonville
- Lauderhill
- Maitland
- Miami
- North Miami
- Wichita
- Lexington
- Fall River
- New Bedford
- Flowood
- St Louis
- Belvidere
- Berlin
- New York
- Canton
- Dayton
- Middleburg Heights
- Oklahoma City
- Conshohocken
- Philadelphia
- Lincoln
- Charleston
- Dallas
- Orem
- Burlington
- Seattle
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Braeburn Pharmaceuticals.
Did this study involve medication?
Yes. The study involved medication, including CAM2038 SC injection, SL BPN/NX tabs, placebo SC injections and SL placebo tablets.
Who was this study for?
Listed age limits: 18 years to 65 years.
